Metallo-β-lactamases: The quiet before the storm?

Clinical Microbiology Reviews

Volumn 18, Issue 2, 2005, Pages 306-325

  Walsh, Timothy R ^a   Toleman, Mark A ^a   Poirel, Laurent ^b   Nordmann, Patrice ^b  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b BICÊTRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

1BETA METHYL CARBAPENEM DERIVATIVE; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPICILLIN; AZLOCILLIN; AZTREONAM; BACTERIAL ENZYME; BETA LACTAM; BETA LACTAMASE; BETA LACTAMASE INHIBITOR; BIPHENYL TETRAZOLE; CARBENICILLIN; CEFALOTIN; CEFEPIME; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CEFUROXIME; CLAVULANIC ACID; CYSTEINE DERIVATIVE; IMIPENEM; LATAMOXEF; MEROPENEM; METALLO BETA LACTAMASE; METALLO BETA LACTAMASE INHIBITOR; NITROCEFIN; PENICILLIN DERIVATIVE; PENICILLIN G; PIPERACILLIN; SULFONYLHYDRAZONE; TAZOBACTAM; THIOESTER; THIOL DERIVATIVE; THIOXOCEPHALOSPORIN; TICARCILLIN; TRICYCLIC AROMATIC COMPOUND; TRIFLUOROMETHYL ALCOHOL; UNCLASSIFIED DRUG;

ACINETOBACTER; ANTIBIOTIC RESISTANCE; ENTEROBACTERIACEAE; ENZYME ACTIVITY; GENE; GIM GENE; HUMAN; HYDROLYSIS; IMP GENE; INTEGRON; NONHUMAN; NUCLEOTIDE SEQUENCE; PSEUDOMONAS AERUGINOSA; REVIEW; SPM GENE; TRANSPOSON; VIM GENE;

BETA-LACTAM RESISTANCE; BETA-LACTAMASES; BETA-LACTAMS; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS;

ACINETOBACTER; ENTEROBACTERIACEAE; PSEUDOMONAS; PSEUDOMONAS AERUGINOSA;

EID: 17444363393     PISSN: 08938512     EISSN: None     Source Type: Journal    
DOI: 10.1128/CMR.18.2.306-325.2005     Document Type: Review

References (203)

1. Afzal-Shah, M., N. Woodford, and D. M. Livermore. 2001. Characterization of OXA-25, OXA-26, and OXA-27, molecular class D β-lactamases associated with carbapenem resistance in clinical isolates of Acinetobacter baumannii. Antimicrob. Agents Chemother. 45:583-588.
2. Ambler, R. P. 1980. The structure of β-lactamases. Phil. Trans. R. Soc. Lond. B. Biol. Sci. 289:321-331.
3. Andrade, S. S., R. N. Jones, A. C. Gales, and H. S. Sader. 2003. Increasing prevalence of antimicrobial resistance among Pseudomonas aeruginosa isolates in Latin American medical centres: 5 year report of the SENTRY Antimicrobial Surveillance Program (1997-2001). J. Antimicrob. Chemother. 52:140-U7.
4. Aoki, S., Y. Hirakata, A. Kondoh, N. Gotoh, K. Yanagihara, Y. Miyazaki, K. Tomono, Y. Yamada, S. Kohno, and S. Kamihira. 2004. Virulence of metallo-β-lactamase-producing Pseudomonas aeruginosa in vitro and in vivo. Antimicrob. Agents Chemother. 48:1876-1878.
5. IMP. Antimicrob. Agents Chemother. 39:1612-1615.
6. Arakawa, Y., N. Shibata, K. Shibayama, H. Kurokawa, T. Yagi, H. Fujiwara, and M. Goto. 2000. Convenient test for screening metallo-β-lactamase- producing gram-negative bacteria by using thiol compounds. J. Clin. Microbiol. 38:40-43.
7. Avison, M. B., C. S. Higgins, C. J. von Heldreich, P. M. Bennett, and T. R. Walsh. 2001. Plasmid location and molecular heterogeneity of the L1 and L2 β-lactamase genes of Stenotrophomonas maltophilia. Antimicrob. Agents Chemother. 45:413-419.
8. Bahar, G., A. Mazzariol, R. Koncan, A. Mert, R. Fontana, G. M. Rossolini, and G. Cornaglia. 2004. Detection of VIM-5 metallo-β-lactamase in a Pseudomonas aeruginosa clinical isolate from Turkey. J. Antimicrob. Chemother. 54:282-283.
9. Beaber, J. W., B. Hochhut, and M. K. Waldor. 2004. SOS response promotes horizontal dissemination of antibiotic resistance genes. Nature 427:72-74.
10. Bellais, S., S. Leotard, L. Poirel, T. Naas, and P. Nordmann. 1999. Molecular characterization of a carbapcnem-hydrolyzing β-lactamase from Chryseobacterium (Flavobacterium) indologenes. FEMS Microbiol. Lett. 171:127-132.
11. Bellais, S., O. Mimoz, S. Leotard, A. Jacolot, O. Petitjean, and P. Nordmann. 2002. Efficacy of β-lactams for treating experimentally induced pneumonia due to a carbapenem-hydrolyzing metallo-β-lactamase-producing strain of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 46: 2032-2034.
12. Bellais, S., T. Naas, and P. Nordmann. 2002. Genetic and biochemical characterization of CGB-1, an ambler class B earbapenem-hydrolyzing β-lactamase from Chryseobacterium gleum. Antimicrob. Agents Chemother. 46: 2791-2796.
13. Bellais, S., L. Poirel, S. Leotard, T. Naas, and P. Nordmann. 2000. Genetic diversity of carbapenem-hydrolyzing metallo-β-lactamases from Chryseobacterium (Fluvobucterium) indologenes. Antimicrob. Agents Chemother. 44:3028-3034.
14. Bennett, P. M. 1999. Integrons and gene cassettes: a genetic construction kit for bacteria. J. Antimicrob. Chemother. 43:1-4.
15. Boschi, L., P. S. Mercuri, M. L. Riccio, G. Amicosante, M. Galleni, J. M. Frere, and G. M. Rossolini. 2000. The Legionella (Fluoribacter) gormanii metallo-β-lactamase: a new member of the highly divergent lineage of molecular-subclass B3 β-lactamases. Antimicrob. Agents Chemother. 44: 1538-1543.
16. Bou, G., A. Oliver, and J. Martinez-Beltran. 2000. OXA-24, a novel class D β-lactamase with carbapenemase activity in an Acinetobacter baumannii clinical strain. Antimicrob. Agents Chemother. 44:1556-1561.
17. Bounaga, S., M. Galleni, A. P. Laws, and M. I. Page. 2001. Cysteinyl peptide inhibitors of Bacillus cereus zinc β-lactamase. Bioorg. Med. Chem. 9:503-510.
18. Bounaga, S., A. P. Laws, M. Galleni, and M. I. Page. 1998. The mechanism of catalysis and the inhibition of the Bacillus cereus zinc-dependent β-lactamase. Biochem. J. 331:703-711.
19. Bradford, P. A. 2001. Extended-spectrum β-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin. Microbiol. Rev. 14:933-951.
20. Bush, K. 1999. β-Lactamases of increasing clinical importance. Curr. Pharm. Des. 5:839-845.
21. Bush, K. 1989. Classification of β-lactamases-group-2c, group-2d, group-2e, group-3, and group-4. Antimicrob. Agents Chemother. 33:271-276.
22. Bush, K. 1998. Metallo-β-lactamases: a class apart. Clin. Infect. Dis. 27: S48-53.
23. Bush, K, 2001. New β-lactamases in gram-negative bacteria: diversity and impact on the selection of antimicrobial therapy. Clin. Infect. Dis. 32:1085-1089.
24. Bush, K., G. A. Jacoby, and A. A. Medeiros. 1995. A functional classification scheme for β-lactamases and its correlation with molecular structure. Antimicrob. Agents Chemother. 39:1211-1233.
25. Buynak, J. D., H. Chen, L. Vogeti, V. R. Gadhachanda, C. A. Buchanan, T. Palzkill, R. W. Shaw, J. Spencer, and T. R. Walsh. 2004. Penicillin-derived inhibitors that simultaneously target both metallo- and serine-β- lactamases. Bioorg. Med. Chem. Lett. 14:1299-1304.
26. Cardoso, O., R. Leitao, A. Figueiredo, J. C. Sousa, A. Duarte, and L. V. Peixe. 2002. Metallo-β-lactamase VIM-2 in clinical isolates of Pseudomonas aeruginosa from Portugal. Microb. Drug Resist. 8:93-97.
27. Carfi, A., E. Duee, M. Galleni, J. M. Frere, and O. Dideberg. 1998. 1.85 A resolution structure of the zinc (II) β-lactamase from Bacillux cereus. Acta Crystallogr. D Biol. Crystallogr. 54:313-323.
28. Carfi, A., E. Duee, R. Paul-Soto, M. Galleni, J. M. Frere, and O. Dideberg. 1998. X-ray structure of the ZnII β-lactamase from Bacteroides fragilis in an orthorhombic crystal form. Acta Crystallogr. D Biol. Crystallogr. 54:45-57.
29. GIM-1, encoding a new subclass of metallo-β-lactamase. Antimicrob. Agents Chemother. 48:4654-4661.
30. Chen, Y. H., J. Succi, F. C. Tenover, and T. M. Koehler. 2003. β-Lactamase genes of the penicillin-susceptible Bacillus anthracis Sterne strain. J. Bacteriol. 185:823-830.
31. Chu, Y. W., M. Afzal-Shah, E. T. Houang, M. I. Palepou, D. J. Lyon, N. Woodford, and D. M. Livermore. 2001. IMP-4, a novel metallo-β-lactamase from nosocomial Acinetobacter spp. collected in Hong Kong between 1994 and 1998. Antimicrob. Agents Chemother. 45:710-714.
32. Collis, C. M., M. J. Kim, H. W. Stokes, and R. M. Hall. 2002. Integron-encoded IntI integrases preferentially recognize the adjacent cognate attl site in recombination with a 59-be site. Mol. Microbiol. 46:1415-1427.
33. Concha, N. O., C. A. Janson, P. Rowling, S. Pearson, C. A. Cheever, B. P. Clarke, C. Lewis, M. Galleni, J. M. Frere, D. J. Payne, J. H. Bateson, and S. S. Abdel-Meguid. 2000. Crystal structure of the IMP-1 metallo β-lactamase from Pseudomonas aeruginosa and its complex with a mercaptocarboxylate inhibitor: binding determinants of a potent, broad-spectrum inhibitor. Biochemistry 39:4288-4298.
34. Concha, N. O., B. A. Rasmussen, K. Bush, and O. Herzberg. 1996. Crystal structure of the wide-spectrum binuclear zinc β-lactamase from Bacteroides fragilis. Structure 4:823-836.
35. Conejo, M. C., I. Garcia, L. Martinez-Martinez, L. Picabea, and A. Pascual. 2003. Zinc eluted from siliconized latex urinary catheters decreases OprD expression, causing carbapenem resistance in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 47:2313-2315.
36. Cornaglia, G., M. L. Riccio, A. Mazzariol, L. Lauretti, R. Fontana, and G. M. Rossolini. 1999. Appearance of IMP-1 metallo-β-lactamase in Europe. Lancet 353:899-900.
37. Crowder, M. W., Z. Wang, S. L. Franklin, E. P. Zovinka, and S. J. Benkovic. 1996. Characterization of the metal-binding sites of the β-lactamase from Bacteroides fragilis. Biochemistry 35:12126-12132.
38. Daiyasu, H., K. Osaka, Y. Ishino, and H. Toh. 2001. Expansion of the zinc metallo-hydrolase family of the β-lactamase fold. FEBS Lett. 503:1-6.
39. IMP-5, a new integron-borne metallo-β-lactamase gene from an Acinetobacter baumannii nosocomial isolate in Portugal. FEMS Microbiol. Lett. 215:33-39.
40. Da Silva, G. J., R. Leitao, and L. Peixe. 1999. Emergence of carbapenem-hydrolyzing enzymes in Acinetobacter baumannii clinical isolates. J. Clin. Microbiol. 37:2109-2110.
41. Docquier, J. D., J. Lamotte-Brasseur, M. Galleni, G. Amicosante, J. M. Frere, and G. M. Rossolini. 2003. On functional and structural heterogeneity of VIM-type metallo-β-lactamases. J. Antimicrob. Chemother. 51:257-266.
42. Docquier, J. D., F. Pantanella, F. Giuliani, M. C. Thaller, G. Amicosante, M. Galleni, J. M. Frere, K. Bush, and G. M. Rossolini. 2002. CAU-1, a subclass B3 metallo-β-lactamase of low substrate affinity encoded by an ortholog present in the Caulobacter crescentus chromosome. Antimicrob. Agents Chemother. 46:1823-1830.
43. Docquier, J. D., M. L. Riccio, C. Mugnaioli, F. Luzzaro, A. Endimiani, A. Toniolo, G. Amicosante, and G. M. Rossolini. 2003. IMP-12, a new plasmid-encoded metallo-β-lactamase from a Pseudomonas putida clinical isolate. Antimicrob. Agents Chemother. 47:1522-1528.
44. Fitzgerald, P. M., J. K. Wu, and J. H. Toney. 1998. Unanticipated inhibition of the metallo-β-lactamase from Bacteroides fragilis by 4-morpholine-ethanesulfonic acid (MES): a crystallographic study at 1.85-A resolution. Biochemistry 37:6791-6800.
45. Frere, J. M. 1995. β-lactamases and bacterial resistance to antibiotics. Mol. Microbiol. 16:385-395.
46. Gales, A. C., L. C. Menezes, S. Silbert, and H. S. Sader. 2003. Dissemination in distinct Brazilian regions of an epidemic carbapenem-resistant Pseudomonas aeruginosa producing SPM metallo-β-lactamase. J. Antimicrob. Chemother. 52:699-702.
47. Gales, A. C., M. C. Tognim, A. O. Reis, R. N. Jones, and H. S. Sader. 2003. Emergence of an IMP-like metallo-enzyme in an Acinetobacter baumannii clinical strain from a Brazilian teaching hospital. Diagn. Microbiol. Infect. Dis. 45:77-79.
48. Galleni, M., J. Lamotte-Brasseur, G. M. Rossolini, J. Spencer, O. Dideberg, and J. M. Frère. 2001. Standard numbering scheme for class B β-lactamases. Antimicrob. Agents Chemother. 45:660-663.
49. Garau, G., C. Bebrone, C. Anne, M. Galleni, J. M. Frere, and O. Dideberg. 2005. A metallo-β-lactamase enzyme in action: Crystal structures of the monozinc carbapenemase CphA and its complex with biapenem. J. Mol. Biol. 345:785-795.
50. Garau, G., I. Garcia-Saez, C. Bebrone, C. Anne, P. Mercuri, M. Galleni, J. M. Frere, and O. Dideberg. 2004. Update of the standard numbering scheme for class B β-lactamases. Antimicrob. Agents Chemother. 48:2347-2349.
51. Garcia-Saez, I., J. Hopkins, C. Papamicael, N. Franceschini, G. Amicosante, G. M. Rossolini, M. Galleni, J. M. Frere, and O. Dideberg. 2003. The 1.5-A structure of Chryseobacterium meningosepticum zinc β-lactamase in complex with the inhibitor, D-captopril. J. Biol. Chem. 278:23868-23873.
52. Garcia-Saez, I., P. S. Mercuri, C. Papamicael, R. Kahn, J. M. Frere, M. Galleni, G. M. Rossolini, and O. Dideberg. 2003. Three-dimensional structure of FEZ-1, a monomeric subclass B3 metallo-β-lactamase from Fluoribacter gormanii, in native form and in complex with D-captopril. J. Mol. Biol. 325:651-660.
53. Giakkimpi, P., A. Xanthaki, M. Kanelopoulou, A. Vlahaki, V. Miriagou, S. Kontou, E. Papafraggas, H. Malamou-Lada, L. S. Tzouvelekis, N. J. Legakis, and A. C. Vatopoulos. 2003. VIM-1 metallo-β-lactamase-producing Klebsiella pneumonia? strains in Greek hospitals. J. Clin. Microbiol. 41: 3893-3896.
54. IMP-7. Antimicrob. Agents Chemother. 46:255-258.
55. Giske, C. G., M. Rylander, and G. Kronvall. 2003. VIM-4 in a carbapenem-resistant strain of Pseudomonas aeruginosa isolated in Sweden. Antimicrob. Agents Chemother. 47:3034-3035.
56. Goto, M., T. Takahashi, F. Yamashita, A. Koreeda, H. Mori, M. Ohta, and Y. Arakawa. 1997. Inhibition of the metallo-β-lactamase produced from Serratia marcescens by thiol compounds. Biol. Pharm. Bull. 20:1136-1140.
57. Greenlee, M. L., J. B. Laub, J. M. Balkovec, M. L. Hammond, G. G. Hammond, D. L. Pompliano, and J. H. Epstein-Toney. 1999. Synthesis and SAR of thioester and thiol inhibitors of IMP-1 metallo-β-lactamase. Bioorg. Med. Chem. Lett. 9:2549-2554.
58. Hammond, G. G., J. L. Huber, M. L. Greenlee, J. B. Laub, K. Young, L. L. Silver, J. M. Balkovec, K. D. Pryor, J. K. Wu, B. Leiting, D. L. Pompliano, and J. H. Toney. 1999. Inhibition of IMP-1 metallo-β-lactamase and sensitization of IMP-1-producing bacteria by thioester derivatives. FEMS Microbiol. Lett. 179:289-296.
59. Hanson, N. D., A. Hossain, L. L. Buck, E. S. Moland, and K. S. Thomson. 2004. Program and abstracts of the 44th Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington, D.C., abstr. C1-291, 2004.
60. Hawkey, P. M., J. Xiong, H. Ye, H. Li, and F. H. M'Zali. 2001. Occurrence of a new metallo-β-lactamase IMP-4 carried on a conjugative plasmid in Citrobacter youngae from the People's Republic of China. FEMS Microbiol. Lett. 194:53-57.
61. Héritier, C., L. Poirel, D. Aubert, and P. Nordmann. 2003. Genetic and functional analysis of the chromosome-encoded carbapenem-hydrolyzing oxacillinasc OXA-40 of Acinetobacter baumannii. Antimicrob. Agents Chemother. 47:268-273.
62. IMP. Antimicrob. Agents Chemother. 42:2006-2011.
63. Ho, S. E., G. Subramaniam, S. Palasubramaniam, and P. Navaratnam. 2002. Carbapenem-resistant Pseudomonas aeruginosa in Malaysia producing IMP-7 β-lactamase. Antimicrob. Agents Chemother. 46:3286-3287.
64. IMP-4) gene cassettes in class 1 integrons in Acinetobacter strains isolated from blood cultures in 1997 to 2000. Antimicrob. Agents Chemother. 47:1382-1390.
65. Hussain, M., A. Carlino, M. J. Madonna, and J. O. Lampen. 1985. Cloning and sequencing of the metallothioprotein β-lactamase II gene of Bacillus cerens 569/H in Escherichia coli. J. Bacteriol. 164:223-229.
66. IMP among clinically isolated strains of Serratia marcescens. Antimicrob. Agents Chemother. 39:824-829.
67. Iwanaga, M., C. Toma, T. Miyazato, S. Insisiengmay, N. Nakasone, and M. Ehara. 2004. Antibiotic resistance conferred by a class I integron and SXT constin in Vibrio cholerae O1 strains isolated in Laos. Antimicrob. Agents Chemother. 48:2364-2369.
68. Iyobe, S., H. Kusadokoro, J. Ozaki, N. Matsumura, S. Minami, S. Haruta, T. Sawai, and K. O'Hara. 2000. Amino acid substitutions in a variant of IMP-1 metallo-β-lactamase. Antimicrob. Agents Chemother. 44:2023-2027.
69. Iyobe, S., H. Kusadokoro, A. Takahashi, S. Yomoda, T. Okubo, A. Nakamura, and K. O'Hara. 2002. Detection of a variant metallo-β-lactamase, IMP-10, from two unrelated strains of Pseudomonas aeruginosa and alcaligenes xylosoxidans strain. Antimicrob. Agents Chemother. 46:2014-2016.
70. Jeong, S. H., K. Lee, Y. Chong, J. H. Yum, S. H. Lee, H. J. Choi, J. M. Kim, K. H. Park, B. H. Han, S. W. Lee, and T. S. Jeong. 2003. Characterization of a new integron containing VIM-2, a metallo-β-lactamase gene cassette, in a clinical isolate of Enterobacter cloacae. J. Antimicrob. Chemother. 51: 397-400.
71. Jin, W. C., Y. Arakawa, H. Yasuzawa, T. Taki, R. Hashiguchi, K. Mitsutani, A. Shoga, Y. Yamaguchi, H. Kurosaki, N. Shibata, M. Ohta, and M. Goto. 2004. Comparative study of the inhibition of metallo-β-lactamases (IMP-1 and VIM-2) by thiol compounds that contain a hydrophobic group. Biol. Pharm. Bull. 27:851-856.
72. Jones, R. N., L. M. Deshpande, T. R. Fritsche, and H. S. Sader. 2004. Determination of epidemic clonality among multidrug-resistant strains of Acinetobacter spp. and Pseudomonas aeruginosa in the MYSTIC Programme (UAS 1999-2003). Diagn. Microbiol. Infect. Dis. 49:211-216.
73. Karabinis, A., E. Paramythiotou, D. Mylona-Petropoulou, A. Kalogeromitros, N. Katsarelis, F. Kontopidou, I. Poularas, and H. Malamou-Lada. 2004. Colistin for Klebsiella pneumoniae-associated sepsis. Clin. Infect. Dis. 38:E7-E9.
74. Koh, T. H., L. H. Sng, G. S. Babini, N. Woodford, D. M. Livermore, and L. M. Hall. 2001. Carbapenem-resistant Klebsiella pneumoniae in Singapore producing IMP-1 β-lactamase and lacking an outer membrane protein. Antimicrob. Agents Chemother. 45:1939-1940.
75. Koh, T. H., G. C. Y. Wang, and L. H. Sng. 2004. IMP-1 and a novel metallo-β-lactamase, VIM-6, in fluorescent pseudomonads isolated in Singapore. Antimicrob. Agents Chemother. 48:2334-2336.
76. Kurosaki, H., H. Yasuzawa, Y. Yamaguchi, W. C. Jin, Y. Arakawa, and M. Goto. 2003. Detection of a metallo-β-lactamase (IMP-1) by fluorescent probes having dansyl and thiol groups. Org. Biomol. Chem. 1:17-20.
77. Lagatolla, C., E. A. Tonin, C. Monti-Bragadin, L. Dolzani, F. Gombac, C. Bearzi, E. Edalucci, F. Gionechetti, and G. M. Rossolini. 2004. Endemic carbapenem-resistant Pseudomonas aeruginosa with acquired metallo-β- lactamase determinants in European hospital. Emerg. Infect. Dis. 10:535-538.
78. Laraki, N., N. Franceschini, G. M. Rossolini, P. Santucci, C. Meunier, E. de Pauw, G. Amicosante, J. M. Frere, and M. Galleni. 1999. Biochemical characterization of the Pseudomonas aeruginosa 101/1477 metallo-β-lactamase IMP-1 produced by Escherichia coli. Antimicrob. Agents Chemother. 43:902-906.
79. VIM, a new integron-borne metallo-β-lactamase gene from a Pseudomonas aeruginosa clinical isolate. Antimicrob. Agents Chemother. 43:1584-1590.
80. Lee, K., W. G. Lee, Y. Uh, G. Y. Ha, J. Cho, and Y. Chong. 2003. VIM- and IMF-type metallo-β-lactamase-producing Pseudomonas spp. and Acinetobacter spp. in Korean hospitals. Emerg. Infect. Dis. 9:868-871.
81. VIM-2 cassette-containing novel integrons in metallo-β-lactamase-producing Pseudomonas aeruginosa and Pseudomonas putida isolates disseminated in a Korean hospital. Antimicrob. Agents Chemother. 46:1053-1058.
82. VIM-4 type metallo-β-lactamase gene from a carbapenem-resistant Pseudomonas aeruginosa clinical isolate in Hungary. Antimicrob. Agents Chemother. 48:3576-3578.
83. Lim, H. M., J. J. Pene, and R. W. Shaw. 1988. Cloning, nucleotide sequence, and expression of the Bacillus cereus 5/B/6 β-lactamase II structural gene. J. Bacteriol. 170:2873-2878.
84. Linden, P. K., S. Kusne, K. Coley, P. Fontes, D. J. Kramer, and D. Paterson. 2003. Use of parenteral colistin for the treatment of serious infection due to antimicrobial-resistant Pseudomonas aeruginosa. Clin. Infect. Dis. 37:E154-E160.
85. Livermore, D. M. 2002. The impact of carbapenemases on antimicrobial development and therapy. Curr. Opin. Investig. Drugs 3:218-224.
86. Livermore, D. M., and N. Woodford. 2000. Carbapenemases: a problem in waiting? Curr. Opin. Microbiol. 3:489-495.
87. Lombardi, G., F. Luzzaro, J. D. Docquier, M. L. Riccio, M. Perilli, A. Coli, G. Amicosante, G. M. Rossolini, and A. Toniolo. 2002. Nosocomial infections caused by multidrug-resistant isolates of Pseudomonas putida producing VIM-1 metallo-β-lactamase. J. Clin. Microbiol. 40:4051-4055.
88. Luzzaro, F., J. D. Docquier, C. Colinon, A. Endimiani, G. Lombardi, G. Amicosante, G. M. Rossolini, and A. Toniolo. 2004. Emergence in Klebsiella pneumoniae and Enterobacter cloacae clinical isolates of the VIM-4 metallo-β-lactamase encoded by a conjugative plasmid. Antimicrob. Agents Chemother. 48:648-650.
89. Mammeri, H., S. Bellais, and P. Nordmann. 2002. Chromosome-encoded β-lactamases TUS-1 and MUS-1 from Myroides odoratus and Myroides odoratimimus (Formerly Flavobacterium odoratum), new members of the lineage of molecular subclass B1 metalloenzymes. Antimicrob. Agents Chemother. 46:3561-3567.
90. Maniatis, A. N., S. Pournaras, S. Orkopoulou, P. T. Tassios, and N. J. Legakis. 2003. Multiresistant Acinetobacter baumannii isolates in intensive care units in Greece. Clin. Microbiol. Infect. 9:547-553.
91. Markou, N., H. Apostolakos, C. Koumoudiou, M. Athanasiou, A. Koutsoukou, I. Alamanos, and L. Gregorakos. 2003. Intravenous colistin in the treatment of sepsis from multiresistant Gram-negative bacilli in critically ill patients. Crit. Care 7:R78-R83.
92. Massidda, O., G. M. Rossolini, and G. Satta. 1991. The Aeromonas Hydrophila cphA gene: molecular heterogeneity among class B metallo-β- lactamases. J. Bacteriol. 173:4611-4617.
93. Mavroidi, A., A. Tsakris, E. Tzelepi, S. Pournaras, V. Loukova, and L. S. Tzouvelekis. 2000. Carbapenem-hydrolysing VIM-2 metallo-β-lactamase in Pseudomonas aeruginosa from Greece. J. Antimicrob. Chemother. 46:1041-1042.
94. McManus-Munoz, S., and M. W. Crowder. 1999. Kinetic mechanism of metallo-β-lactamase L1 from Stenotrophomonas maltophilia. Biochemistry 38:1547-1553.
95. Melino, S., C. Capo, B. Dragani, A. Aceto, and R. Petruzzelli. 1998. A zinc-binding motif conserved in glyoxalase 11, β-lactamase and arylsulfatases. Trends Biochem. Sci. 23:381-382.
96. VIM-2 in Latin America: Report from the SENTRY Antimicrobial Surveillance Program. Antimicrob. Agents Chemother. 48:1433-1434.
97. IMP with a unique genetic context. Report from the SENTRY Antimicrobial Surveillance Program. Antimicrob. Agents Chemother. 48:4654-4661.
98. Migliavacca, R., C. Colinon, J. D. Docquier, M. Spalla, E. Nucleo, M. Li Bergoli, M. Labonia, G. M. Rossolini, and L. Pagani. 2004. Abstr. 14th European Congress on Clinical Microbiology and Infectious Diseases, abstr. P1876, 2004.
99. Migliavacca, R., J. D. Docquier, C. Mugnaioli, G. Amicosante, R. Daturi, K. W. Lee, G. M. Rossolini, and L. Pagani. 2002. Simple microdilution test for detection of metallo-β-lactamase production in Pseudomonas aeruginosa. J. Clin. Microbiol. 40:4388-4390.
100. Miller, L. A., K. Ratnam, and D. J. Payne. 2001. β-lactamase- inhibitor combinations in the 21st century: current agents and new developments, Curr. Opin. Pharm. 1:451-458.
101. Mollard, C., C. Moali, C. Papamicael, C. Damblon, S. Vessilier, G. Amicosante, C. J. Schofield, M. Galleni, J. M. Frere, and G. C. Roberts. 2001. Thiomandelic acid, a broad spectrum inhibitor of zinc β-lactamases: kinetic and spectroscopic studies. J. Biol. Chem. 276:45015-45023.
102. Murphy, T. A., A. M. Simm, M. A. Toleman, R. N. Jones, and T. R. Walsh. 2003. Biochemical characterization of the acquired metallo-β-lactamase SPM-1 from Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 47: 582-587.
103. Naas, T., S. Bellais, and P. Nordmann. 2003. Molecular and biochemical characterization of a carbapenem-hydrolysing β-lactamase from Flavobacterium johnsoniae. J. Antimicrob. Chemother. 51:267-273.
104. Nagano, R., Y. Adachi, T. Hashizume, and H. Morishima. 2000. In vitro antibacterial activity and mechanism of action of J.-111,225, a novel 1β-methylcarbapenem, against transferable IMP-1 metallo-β-lactamase producers. J. Antimicrob. Chemother. 45:271-276.
105. Nagano, R., Y. Adachi, H. Imamura, K. Yamada, T. Hashizume, and H. Morishima. 1999. Carbapenem derivatives as potential inhibitors of various β-lactamases, including class B metallo-β-lactamases. Antimicrob. Agents Chemother. 43:2497-2503.
106. Neuhauser, M. M., R. A. Weinstein, R. Rydman, L. H. Danziger, G. Karam, and J. P. Quinn. 2003. Antibiotic resistance among gram-negative bacilli in US intensive care units-implications for fluoroquinolone use. JAMA 289: 885-888.
107. Nordmann, P., S. Mariotte, T. Naas, R. Labia, and M. H. Nicolas. 1993. Biochemical properties of a carbapenem-hydrolyzing β-lactamase from Enterobacter cloacae and cloning of the gene into Escherichia coli. Antimicrob. Agents Chemother. 37:939-946.
108. Nordmann, P., and L. Poirel. 2002. Emerging carbapenemases in Gram-negative aerobes. Clin. Microbiol. Infect. 8:321-331.
109. Oh, E. J., S. Lee, Y. J. Park, J. J. Park, K. Park, S. I. Kim, M. W. Kang, and B. K. Kim. 2003. Prevalence of metallo-β-lactamase among Pseudomonas aeruginosa and Acinetobacter baumannii in a Korean university hospital and comparison of screening methods for detecting metallo-β- lactamase. J. Microbiol. Methods 54:411-418.
110. Osano, E., Y. Arakawa, R. Wacharotayankun, M. Ohta, T. Horii, H. Ito, F. Yoshimura, and N. Kato. 1994. Molecular characterization of an enterobacterial metallo-β-lactamase found in a clinical isolate of Serratia marcescens that shows imipenem resistance. Antimicrob. Agents Chemother. 38:71-78.
111. Page, M. I. 1999. The reactivity of β-lactams, the mechanism of catalysis and the inhibition of β-lactamases. Curr. Pharm. Des. 5:895-913.
112. Page, M. I. 2002. Understanding metallo-β-lactamases. ASM News 68: 217-221.
113. Pagniez, G., M. Radice, A. Amoroso, A. Famiglietti, and G. Gutkind. 2004. Abstr. 44th Interscience Conference on Antimicrobial Agents and Chemotherapy, abstr. C1-293, Washington, D.C.
114. VIM-2-containing integrons from Pseudomonas aeruginosa plasmids encoding the VIM-2 metallo-β-lactamase. FEMS Microbiol. Lett. 195:145-150.
115. Partridge, S. R., and R. M. Hall. 2003. The IS1111 family members IS4321 and 1S5075 have subterminal inverted repeats and target the terminal inverted repeats of Tn21 family transposons. J. Bacteriol. 185:6371-6384.
116. VIM-4 gene cassette isolated from hospitalized children in Poland (1998-2001). J. Antimicrob. Chemother. 53:451-456.
117. Payne, D. J. 1993. Metallo-β-lactamases - a new therapeutic challenge. J. Med. Microbiol. 39:93-99.
118. Payne, D. J., J. H. Bateson, B. C. Gasson, T. Khushi, D. Proctor, S. C. Pearson, and R. Reid. 1997. Inhibition of metallo-β-lactamases by a series of thiol ester derivatives of mercaptophenylacetic acid. FEMS Microbiol. Lett. 157:171-175.
119. Payne, D. J., J. H. Bateson, B. C. Gasson, D. Proctor, T. Khushi, T. H. Farmer, D. A. Tolson, D. Bell, P. W. Skett, A. C. Marshall, R. Reid, L. Ghosez, Y. Combret, and J. Marchand-Brynaert. 1997. Inhibition of metallo-β- lactamases by a series of mercaptoacetic acid thiol ester derivatives. Antimicrob. Agents Chemother. 41:135-140.
120. Payne, D. J., R. Cramp, J. H. Bateson, J. Neale, and D. Knowles. 1994. Rapid identification of metallo- and serine β-lactamase. Antimicrob. Agents Chemother. 38:991-996.
121. Payne, D. J., W. Du, and J. H. Bateson. 2000. β-Lactamase epidemiology and the utility of established and novel β-lactamase inhibitors. Expert Opin. Investig. Drugs 9:247-261.
122. Payne, D. J., J. A. Hueso-Rodriguez, H. Boyd, N. O. Concha, C. A. Janson, M. Gilpin, J. H. Bateson, C. Cheever, N. L. Niconovich, S. Pearson, S. Rittenhouse, D. Tew, E. Diez, P. Perez, J. De La Fuente, M. Rees, and A. Rivera-Sagredo. 2002. Identification of a series of tricyclic natural products as potent broad-spectrum inhibitors of metallo-β-lactamases. Antimicrob. Agents Chemother. 46:1880-1886.
123. Peleg, A. Y., C. Franklin, J. Bell, and D. W. Spelman. 2004. Emergence of IMP-4 metallo-β-lactamase in a clinical isolate from Australia. J. Antimicrob. Chemother. 54:699-700.
124. Perron, K., O. Caille, C. Rossier, C. van Delden, J. L. Dumas, and T. Kohler. 2004. CzcR-CzcS, a two-component system involved in heavy metal and carbapenem resistance in Pseudomonas aeruginosa. 3. Biol. Chem. 279:8761-8768.
125. Podglajen, I, J. Breuil, I. Casin, and E. Collatz. 1995. Genotypic identification of two groups within the species Bacteroides fragilis by ribotyping and by analysis of PCR-generated fragment patterns and insertion sequence content. J. Bacteriol. 177:5270-5275.
126. Podglajen, I., J. Breuil, and E. Collatz. 1994. Insertion of a novel DNA sequence, IS1186, upstream of the silent carbapcnemase gene cfiA, promotes expression of carbapenem resistance in clinical isolates of Bacteroides fragilis. Mol. Microbiol. 12:105-114.
127. Poirel, L., L. Collet, and P. Nordmann. 2000. Carbapenem-hydrolyzing metallo-β-lactamase from a nosocomial isolate of Pseudomonas aeruginosa in France. Emerg. Infect. Dis. 6:84-85.
128. Poirel, L., C. Heritier, and P. Nordmann. 2004. Chromosome-encoded ambler class D β-lactamase of Shewanella oneidensis as a progenitor of carbapenem-hydrolyzing oxacillinase. Antimicrob. Agents Chemother. 48:348-351.
129. VIM-2 carbapenem-hydrolyzing β-lactamase gene and of two novel aminoglycoside resistance gene cassettes. Antimicrob. Agents Chemother. 45:546-552.
130. SPM-1-surrounding sequences from disseminated Pseudomonas aeruginosa isolates in Recife, Brazil. Antimicrob. Agents Chemother. 48:1406-1409.
131. Poirel, L., T. Naas, D. Nicolas, L. Collet, S. Bellais, J. D. Cavallo, and P. Nordmann. 2000. Characterization of VIM-2, a carbapenem-hydrolyzing metallo-β-lactamase and its plasmid- and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France. Antimicrob. Agents Chemother. 44:891-897.
132. Poirel, L., J. N. Pham, L. Cabanne, B. J. Gatus, S. M. Bell, and P. Nordmann. 2004. Carbapenem-hydrolysing metallo-β-lactamases from Klebsiella pneumoniae and Escherichia coli isolated in Australia. Pathology (Philadelphia) 36:366-367.
133. Poirel, L., G. F. Weldhagen, T. Naas, C. De Champs, M. G. Dove, and P. Nordmann. 2001. GES-2, a class A β-lactamase from Pseudomonas aeruginosa with increased hydrolysis of imipenem. Antimicrob. Agents Chemother. 45:2598-2603.
134. Poole, K. 2003. Overcoming multidrug resistance in gram-negative bacteria. Curr. Opin. Investig. Drugs 4:128-139.
135. VIM-4. J. Antimicrob. Chemother. 51:1409-1414.
136. VIM-1 in a clinical strain of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 46:4026-4028.
137. Prats, G., E. Miro, B. Mirelis, L. Poirel, S. Bellais, and P. Nordmann. 2002. First isolation of a carbapenem-hydrolyzing β-lactamase in Pseudomonas aeruginosa in Spain. Antimicrob. Agents Chemother. 46:932-933.
138. Projan, S. J. 2003. Why is big Pharma getting out of antibacterial drug discovery? Curr. Opin. Microbiol. 6:427-430.
139. Queenan, A. M., C. Torres-Viera, H. S. Gold, Y. Carmeli, G. M. Eliopoulos, R. C. Moellering, J. P. Quinn, J. Hindler, A. A. Medeiros, and K. Bush. 2000. SME-type carbapenem-hydrolyzing class A β-lactamases from geographically diverse Serratia marcescens strains. Antimicrob. Agents Chemother. 44:3035-3039.
140. Quiroga, M. I., N. Franceschini, G. M. Rossolini, G. Gutkind, G. Bonfiglio, L. Franchino, and G. Amicosante. 2000. Interaction of cefotetan and the metallo-β-lactamases produced in Aeromonas spp. and in vitro activity. Chemotherapy 46:177-183.
141. Rasmussen, B. A., and K. Bush. 1997. Carbapenem-hydrolyzing β-lactamases. Antimicrob. Agents Chemother. 41:223-232.
142. Rasmussen, B. A., K. Bush, D. Keeney, Y. J. Yang, R. Hare, C. Ogara, and A. A. Medeiros. 1996. Characterization of IMI-1 β-lactamase, a class A carbapenem-hydrolyzing enzyme from Enterobacter cloacae. Antimicrob. Agents Chemother. 40:2080-2086.
143. Rasmussen, B. A., and E. Kovacs. 1991. Identification and DNA sequence of a new Bacteroides fragilis insertion sequence-like clement. Plasmid 25: 141-144.
144. IMP allelic variants carried by gene cassettes of different phylogeny. Antimicrob. Agents Chemother. 44:1229-1235.
145. VIM-1-containing integron carrying a new aminoglycoside phosphotransferase gene cassette. Antimicrob. Agents Chemother. 45:1249-1253.
146. Rossolini, G. M., M. A. Condemi, F. Pantanella, J. D. Docquier, G. Amicosante, and M. C. Thaller. 2001. Metallo-β-lactamase producers in environmental microbiota: new molecular class B enzyme in Janthinobacterium lividum. Antimicrob. Agents Chemother. 45:837-844.
147. CME) encoding an extended-spectrum class A β-lactamase related to the Bacteroides cephalosporinases and the VEB-1 and PER β-lactamases. Antimicrob. Agents Chemother. 43:2193-2199.
148. Rossolini, G. M., N. Franceschini, M. L. Riccio, P. S. Mercuri, M. Perilli, M. Galleni, J. M. Frere, and G. Amicosante. 1998. Characterization and sequence of the Chryseobacterium (Flavobacterium) meningosepticum carbapenemase: a new molecular class B β-lactamase showing a broad substrate profile. Biochem. J. 332:145-152.
149. Saavedra, M. J., L. Peixe, J. C. Sousa, I. Henriques, A. Alves, and A. Correia. 2003. Sfh-1, a subclass B2 metallo-β-lactamase from a Serratia fonticola environmental isolate. Antimicrob. Agents Chemother. 47:2330-2333.
150. Sahud, A., K. Lilians, A. M. Queenan, and J. P. Quinn. 2004. Presented at the 44th Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington, D.C.
151. Sanschagrin, F., J. Dufresne, and R. C. Levesque. 1998. Molecular heterogeneity of the L-1 metallo-β-lactamase family from Stenotrophomonas maltophilia. Antimicrob. Agents Chemother. 42:1245-1248.
152. Sardelic, S., L. Pallecchi, V. Punda-Polic, and G. M. Rossolini. 2003. Carbapenem-resistant Pseudomonas aeruginosa-carrying VIM-2 metallo-β- lactamase determinants, Croatia. Emerg. Infect. Dis. 9:1022-1023.
153. Schilling, O., N. Wenzel, M. Naylor, A. Vogel, M. Crowder, C. Makaroff, and W. Meyer-Klaucke. 2003. Flexible metal binding of the metallo-β- lactamase domain: glyoxalase II incorporates iron, manganese, and zinc in vivo. Biochemistry 42:11777-11786.
154. VIM-1 metallo-β-lactamase gene. Diagn. Microbiol. Infect. Dis. 48:167-172.
155. Scrofani, S. D., J. Chung, J. J. Huntley, S. J. Benkovic, P. E. Wright, and H. J. Dyson. 1999. NMR characterization of the metallo-β-lactamase from Bacteroides fragilis and its interaction with a tight-binding inhibitor: role of an active-site loop. Biochemistry 38:14507-14514.
156. IMP) in gram-negative rods resistant to broad-spectrum β-lactams. J. Clin. Microbiol. 34:2909-2913.
157. Senda, K., Y. Arakawa, K. Nakashima, H. Ito, S. Ichiyama, K. Shimokata, N. Kato, and M. Ohta. 1996. Multifocal outbreaks of metallo-β-lactamase- producing Pseudomonas aeruginosa resistant to broad-spectrum β-lactams, including carbapenems. Antimicrob. Agents Chemother. 40:349-353.
158. Shibata, N., Y. Doi, K. Yamane, T. Yagi, H. Kurokawa, K. Shibayama, H. Kato, K. Kai, and Y. Arakawa. 2003. PCR typing of genetic determinants for metallo-β-lactamases and integrases carried by gram-negative bacteria isolated in Japan, with focus on the class 3 integron. J. Clin. Microbiol. 41: 5407-5413.
159. Siemann, S., A. J. Clarke, T. Viswanatha, and G. I. Dmitrienko. 2003. Thiols as classical and slow-binding inhibitors of IMP-1 and other binuclear metallo-β-lactamases. Biochemistry 42:1673-1683.
160. Siemann, S., D. P. Evanoff, L. Marrone, A. J. Clarke, T. Viswanatha, and G. I. Dmitrienko. 2002. N-Arylsulfonyl hydrazones as inhibitors of IMP-1 metallo-β-lactamase. Antimicrob. Agents Chemother. 46:2450-2457.
161. Simm, A. M., C. S. Higgins, S. T. Pullan, M. B. Avison, P. Niumsup, O. Erdozain, P. M. Bennett, and T. R. Walsh. 2001. A novel metallo-β- lactamase, MbIIb, produced by the environmental bacterium Caulobacter crescentus. FEBS Lett. 509:350-354.
162. Spencer, J., A. R. Clarke, and T. R. Walsh. 2001. Novel mechanism of hydrolysis of therapeutic β-lactams by Stenotrophomonas multophilia L1 metallo-β-lactamase. J. Biol. Chem. 276:33638-33644.
163. Spencer, J., A. M. Simm, A. R. Clarke, R. B. Sessions, and T. R. Walsh. 2003. Abstr. 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, Ill., abstr. C1-568.
164. Thompson, J. S., and M. H. Malamy. 1990. Sequencing of the gene for an imipenem-cefoxitin-hydrolyzing enzyme (CfiA) from Bacteroides fragilis TAL2480 reveals strong similarity between CfiA and Bacillus cereus β-lactamase BCI1. J. Bacteriol. 172:2584-2593.
165. IMP-13, harboured by a novel Tn5051-type transposon disseminating carbapenemase genes in Europe: report from the SENTRY worldwide antimicrobial surveillance programme. J. Antimicrob. Chemother. 52:583-590.
166. VIM-7, an evolutionary distinct metallo-β-lactamase gene in a Pseudomonas aeruginosa isolate from the United States. Antimicrob. Agents Chemother. 48: 329-332.
167. Toleman, M. A., A. M. Simm, T. A. Murphy, A. C. Gales, D. J. Biedenbach, R. N. Jones, and T. R. Walsh. 2002. Molecular characterization of SPM-1, a novel metallo-β-lactamase isolated in Latin America: report from the SENTRY antimicrobial surveillance programme. J. Antimicrob. Chemother. 50:673-679.
168. Toney, J. H. 2003. Metallo-β-lactamase inhibitors: could they give old antibacterials new life? Curr. Opin. Investig. Drugs 4:115-116.
169. Toney, J. H., K. A. Cleary, G. G. Hammond, X. Yuan, W. J. May, S. M. Hutchins, W. T. Ashton, and D. E. Vanderwall. 1999. Structure-activity relationships of biphenyl tetrazoles as metallo-β-lactamase inhibitors. Bioorg. Med. Chem. Lett. 9:2741-2746.
170. Toney, J. H., P. M. Fitzgerald, N. Grover-Sharma, S. H. Olson, W. J. May, J. G. Sundelof, D. E. Vanderwall, K. A. Cleary, S. K. Grant, J. K. Wu, J. W. Kozarich, D. L. Pompliano, and G. G. Hammond. 1998. Antibiotic sensitization using biphenyl tetrazoles as potent inhibitors of Bacteroides fragilis metallo-β-lactamase. Chem. Biol. 5:185-196.
171. Toney, J. H., G. G. Hammond, P. M. Fitzgerald, N. Sharma, J. M. Balkovec, G. P. Rouen, S. H. Olson, M. L. Hammond, M. L. Greenlee, and Y. D. Gao. 2001. Succinic acids as potent inhibitors of plasmid-borne IMP-1 metallo-β- lactamase. J. Biol. Chem. 276:31913-31918.
172. Towner, K. J., T. Gee, and T. Boswell. 2002. An unwanted import to the UK: a carbapenem-resistant clinical isolate of Acinetobacter baumannii producing metallo-β-lactamase. J. Antimicrob. Chemother. 50:1092-1093.
173. Tsang, W. Y., A. Dhanda, C. J. Schofield, J. M. Frere, M. Galleni, and M. I. Page. 2004. The inhibition of metallo-β-lactamasc by thioxo-cephalosporin derivatives. Bioorg. Med. Chem. Lett. 14:1737-1739.
174. Tysall, L., M. W. Stockdale, P. R. Chadwick, M. F. Palepou, K. J. Towner, D. M. Livermore, and N. Woodford. 2002. IMP-1 carbapenemase detected in an Acinetobacter clinical isolate from the UK. J. Antimicrob. Chemother. 49:217-218.
175. Ullah, J. H., T. R. Walsh, I. A. Taylor, D. C. Emery, C. S. Verma, S. J. Gamblin, and J. Spencer. 1998. The crystal structure of the L1 metallo-β-lactamase from Stenotrophomonas maltophilia at 1.7 A resolution. J. Mol. Biol. 284:125-136.
176. Urban, C., S. Segal-Maurer, and J. J. Rahal. 2003. Considerations in control and treatment of nosocomial infections due to multidrug-resistant Acinetobacter baumannii. Clin. Infect. Dis. 36:1268-1274.
177. Walsh, T. R., A. Bolmstrom, A. Qwarnstrom, and A. Gales. 2002. Evaluation of a new Etest for detecting metallo-β-lactamases in routine clinical testing. J. Clin. Microbiol. 40:2755-2759.
178. Walsh, T. R., L. Hall, S. J. Assinder, W. W. Nichols, S. J. Cartwright, A. P. MacGowan, and P. M. Bennett. 1994. Sequence analysis of the L1 metallo-β-lactamase from Xanthomonas maltophilia. Biochim. Biophys. Acta 1218: 199-201.
179. Walsh, T. R., A. P. MacGowan, and P. M. Bennett. 1997. Sequence analysis and enzyme kinetics of the L2 serine β-lactamase from Stenotrophomonas maltophilia. Antimicrob. Agents Chemother. 41:1460-1464.
180. Walsh, T. R., W. A. Neville, M. H. Haran, D. Tolson, D. J. Payne, J. H. Bateson, A. P. MacGowan, and P. M. Bennett. 1998. Nucleotide and amino acid sequences of the metallo-β-lactamasc, ImiS, from Aeromonas veronii bv. sobria. Antimicrob. Agents Chemother. 42:436-439.
181. VIM-2 in Eastern Europe: report from the SENTRY Antimicrobial Surveillance Program. J. Antimicrob. Chemother. 52:116-119.
182. Walter, M. W., A. Felici, M. Galleni, R. P. Soto, R. M. Adlington, J. E. Baldwin, J.-M. Frère, M. Gololobov, and C. J. Schofield. 1996. Trifluoromethyl alcohol and ketone inhibitors of metallo-β-lactamases. Bioorg. Med. Chem. Lett. 6:2455-2458.
183. Wang, Z., and S. J. Benkovic. 1998. Purification, characterization, and kinetic studies of a soluble Bacteroides fragilis metallo-β-lactamase that provides multiple antibiotic resistance. J. Biol. Chem. 273:22402-22408.
184. Wang, Z., W. Fast, and S. J. Benkovic. 1998. Direct observation of an enzyme-bound intermediate in the catalytic cycle of the metallo-β-lactamase from Bacteroides fragilis. J. Am. Chem. Soc. 120:10788-10789.
185. Wang, Z., W. Fast, and S. J. Benkovic. 1999. On the mechanism of the metallo-β-lactamase from Bacteroides fragilis. Biochemistry 38:10013-10023.
186. Wang, Z., W. Fast, A. M. Valentine, and S. J. Benkovic. 1999. Metallo-β-lactamase: structure and mechanism. Curr. Opin. Chem. Biol. 3:614-622.
187. Watanabe, M., S. Iyobe, M. Inoue, and S. Mitsuhashi. 1991. Transferable imipenem resistance in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 35:147-151.
188. Woodford, N., M. F. Palepou, G. S. Babini, B. Holmes, and D. M. Livermore. 2000. Carbapenemases of Chryscobacterium (Flavobacterium) meningosepticum: distribution of blaB and characterization of a novel metallo-β-lactamase gene, blaB3, in the type strain, NCTC 10016. Antimicrob. Agents Chemother. 44:1448-1452.
189. Wouters, M. A., and A. Husain. 2001. Changes in zinc ligation promote remodeling of the active site in the zinc hydrolase superfamily. J. Mol. Biol. 314:1191-1207.
190. Yamasaki, K., M. Komatsu, T. Yamashita, K. Shimakawa, T. Ura, H. Nishio, K. Satoh, R. Washidu, S. Kinoshita, and M. Aihara. 2003. Production of CTX-M-3 extended-spectrum β-lactamase and IMP-1 metallo β-lactamase by five Gram-negative bacilli: survey of clinical isolates from seven laboratories collected in 1998 und 2000, in the Kinki region of Japan. J. Antimicrob. Chemother. 51:631-638.
191. Yamazoe, K., N. Kato, H. Kato, K. Tanaka, Y. Katagiri, and K. Watanabe. 1999. Distribution of the cfiA gene among Bacteroides fragilis strains in Japan and relatedness of cfiA to imipenem resistance. Antimicrob. Agents Chemother. 43:2808-2810.
192. Van, J. J., P. R. Hsueh, W. C. Ko, K. T. Luh, S. H. Tsai, H. M. Wu, and J. J. Wu. 2001. Metallo-β-lactamases in clinical Pseudomonas isolates in Taiwan and identification of VIM-3, a novel variant of the VIM-2 enzyme. Antimicrob. Agents Chemother. 45:2224-2228.
193. Yan, J. J., W. C. Ko, C. L. Chuang, and J. J. Wu. 2002. Metallo-β-lactamase-producing Enterobacteriaceae isolates in a university hospital in Taiwan: prevalence of IMP-8 in Enterobacter cloacae and first identification of VIM-2 in Citrobacter freundii. J. Antimicrob. Chemother. 50:503-511.
194. IMP-8 in a university medical center in Taiwan. J. Clin. Microbiol. 39: 4433-4439.
195. Yan, J. J., J. J. Wu, S. H. Tsai, and C. L. Chuang. 2004. Comparison of the double-disk, combined disk, and Etest methods for detecting metallo-β-lactamases in gram-negative hacilli, Diagn. Microbiol. Infect. Dis. 49:5-11.
196. Yang, Y., and K. Bush. 1996. Biochemical characterization of the carbapenem-hydrolyzing β-lactamase AsbM1 from Aeromonas sobria AER 14M: a member of a novel subgroup of metallo-β-lactamases. FEMS Microbiol. Lett. 137:193-200.
197. Yang, Y. J., P. J. Wu, and D. M. Livermore. 1990. Biochemical characterization of a β-lactamase that hydrolyzes penems and carbapenems from two Serratia marcescens isolates. Antimicrob. Agents Chemother. 34:755-758.
198. Yano, H., A. Kuga, R. Okamoto, H. Kitasato, T. Kobayashi, and M. Inoue. 2001. Plasmid-encoded metallo-β-lactamase (IMP-6) conferring resistance to carbapenems, especially meropenem. Antimicrob. Agents Chemother. 45:1343-1348.
199. VIM-2 in Pseudomonas aeruginosa clinical strains isolated in Japan. Antimicrob. Agents Chemother. 48:626-628.
200. Yigit, H., A. M. Queenan, G. J. Anderson, A. Domenech-Sanchez, J. W. Biddle, C. D. Steward, S. Alberti, K. Bush, and F. C. Tenover. 2001. Novel carbapenem-hydrolyzing β-lactamasc, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob. Agents Chemother. 45:1151-1161.
201. IMP in a hospital in Japan. J. Clin. Microbiol. 41:4246-4251.
202. Yong, D., K. Lee, J. H. Yum, H. B. Shin, G. M. Rossolini, and Y. Chong. 2002. Imipenem-EDTA disk method for differentiation of metallo-β-lactamase- producing clinical isolates of Pseudomonas spp. and Acinetobacter spp. J. Clin. Microbiol. 40:3798-3801.
203. Yum, J. H., D. Yong, K. Lee, H. S. Kim, and Y. Chong. 2002. A new integron carrying VIM-2 metallo-β-lactamasc gene cassette in a Serratia marcescens isolate. Diagn. Microbiol. Infect. Dis. 42:217-219.